Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik or laser vision correction, which is a great option for those who…
Jonathan Sears, MD, Associate Professor of Ophthalmology, Cole Eye Institute, Cleveland Clinic, discusses retinopathy of prematurity, which affects 10-15% of the 500,000 premature infants born annually in the…
NEW YORK (Reuters Health) – The outcome of treatment for early prostate cancer depends on the patient’s sexual, bowel and urinary function at baseline. These factors also influence…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
